Available online on 15.01.2023 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2023 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access   Full Text Article                                                                                                                                                                Research Article 

Synthesis, Characterization, and Anti-inflammatory activity of Some   Novel Oxazole Derivatives

Ajay Kumar Garg*1 , Ranjan Kumar Singh2 , Vaibhav Saxena3 , Saurabh Kr. Sinha4, Sanjay Rao5 

Department of Pharmaceutical Sciences, Raffles University, Japanese Zone, NH-8, Neemrana, Rajasthan-301020, India

2 Department of Pharmaceutical Sciences, Raffles University, Japanese Zone, NH-8, Neemrana, Rajasthan-301020, India

Department of Pharmaceutical Sciences, Regional College of Pharmacy, Sitapura, Jaipur, Rajasthan-302022, India

Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan-313001, India

Department of Pharmaceutical Sciences, Goenka College of Pharmacy, Sikar, Rajasthan-332315, India

Article Info:

_______________________________________________

Article History:

Received 09 Nov 2022      

Reviewed 12 Dec 2022

Accepted 29 Dec 2022  

Published 15 Jan 2023  

_______________________________________________

Cite this article as: 

Garg AK, Singh RK, Saxena V, Sinha SK, Rao S, Synthesis, Characterization, and Anti-inflammatory activity of Some   Novel Oxazole Derivatives, Journal of Drug Delivery and Therapeutics. 2023; 13(1):26-28

DOI: http://dx.doi.org/10.22270/jddt.v13i1.5719                 _______________________________________________*Address for Correspondence:  

Ajay Kumar Garg, Department of Pharmaceutical Sciences, Raffles University, Japanese Zone, NH-8, Neemrana, Rajasthan-301020, India

Abstract

___________________________________________________________________________________________________________________

A series of novel oxazole derivatives (A, A1, A2) were synthesized starting from acetone and urea. The compound (A) was obtained by heating it with acetophenone and urea in iodine. Compound (A) on treatment with 4-amino benzaldehyde (Z)-N-(4-amino benzylidine)-4-((E)-Penta-2, 4-diene-2) oxazole-2-amine afforded (A1). Acylation of compound (A) with 4-amino benzoyl chloride to obtain the corresponding N-(4 phenyl oxazole-2- yl)- benzamide (A2). The structures of compounds have been established employing FTIR and 1H-NMR spectral analysis. All oxazole derivatives were evaluated for anti-inflammatory activity by the carrageenan-induced Rat hind paw method. Derivative A1 shows maximum anti-inflammatory activity.

Keywords: Oxazoles, anti-inflammatory, Benzamide, acetophenone, indomethacin.

 


 

INTRODUCTION

Numerous medications and physiologically significant compounds have heterocyclic systems. One such moiety that has received attention recently is oxazole because of its growing significance in the field of medicinal chemistry 1. Oxazole-containing secondary metabolites and oxazoline skeletons, which are frequently generated from amino acids, are widely distributed in nature 2. oxazoles are characterized by having oxygen and nitrogen atoms in a 1,3 connection on a five-membered ring 3. Exhibiting extensive biological activities such as antibacterial, antifungal, antiviral, antitubercular, anticancer, anti-inflammatory, and so on, oxazole compounds in medicinal chemistry could easily connect with a range of enzymes and receptors in biological systems 4. The local reaction of living mammalian tissues to harm caused by any substance is known as inflammation. In particular, it is a set of molecular and cellular reactions that have evolved to eradicate invading agents and promote tissue restoration 5. Benzoxazole is the name given to benzo derivatives of oxazole. Oxazolines are the names for partially reduced oxazoles and include 2-oxazoline, 3-oxazoline, and 4-oxazoline  respectively. Oxazolidine is the name for the fully saturated equivalent 3.

MATERIALS AND METHODS 

Chemistry 6

The melting point of the compound synthesized was uncorrected and recorded by open glass capillary method on the “Janki implex melting point apparatus” and compared with the reported melting point wherever applicable 1H-NMR spectra and 13CNMR spectra were reported on GEOLAR -300 shifts were expressed in parts per million (ppm). IR spectra were recorded using “BRUKER ALFA–E infrared spectrophotometer. Analytical thin layer chromatography (TLC) was carried out on pre-coated plates (silica gel G254).

Synthesis of (Z)-N-(4-aminobenzylidine)-4-((E)-penta-2,4-diene-2)oxazole-2-amine (A1). 

A mixture of compound (A) (Scheme.1) and 4-amino benzaldehyde was dissolved in ethyl acetate: n-hexane, 1:5, v/v), and the solvent was evaporated under reduced pressure. The obtained solid mass recrystallized from ethyl acetate and n-hexane solvent mixture.

Yield:  52.0%, m.p.:  178 C, RF 0.50, Silica gel G;  Hexane;  Ethyl acetate   (1:5)

IR (KBr, cm-1): 3169 (C-H, aromatic), 1581 (C=N), 1555 (C-O) stretching1H-NMR (CDCl3) σ (ppm): 8.22 (d, 2H, aromatic), 7.62 (s, 1H, = CH), 7.69 (s, 1H, -CH oxazole), 7.4-7.6 (m, 5H, ph), 4.25

Synthesis of N-(4 phenyloxazole-2- yl)- benzamide (A2)

A mixture of 4-Phenyl oxazole -2- amine (A) (2m mol) with 4-amino benzoyl chloride (2.1m mol) was dissolved in dry pyridine (5 ml). The reaction mixture was kept in an ice bath for 6 hours with continuous stirring. After completion of the reaction, the mixture was poured into ice water and extracted with CHCl3. The organic layer was washed with Dil. NaHCO3 and the solvent were evaporated under reduced pressure. The obtained solid mass was recrystallized from an ethyl acetate and n-hexane solvent mixture. The product was checked for purity on TLC.

Yield:  48.0%, m.p.:  more than250 C, RF 0.50, Silica gel G;  Hexane;  Ethyl acetate (1:5)

IR (KBr, cm-1): 3165 (N-H), 3023 (C-H, aromatic), 3065 (C=C), 1580 (C=N) for oxazole ring, 1620 (C-O), 3072 (C-N). 1H-NMR (CDCl3) σ (ppm): 7.32 (d, 2H, aromatic), 7.63 (s, 1H,-CH, oxazole), 7.35-7.21 (m, 5H, ph), 8.00 (s, 1H, NH), 7.95(CO).


 

 

 

Scheme1. Synthetic Pathways for the Preparation of(Z)-N-(4-aminobenzylidine)-4-((E)-penta-2,4-diene-2)oxazole-2-amine (A1) and N-(4 phenyloxazole-2- yl)- benzamide.(A2)

 


 

Carrageenan Induced Rat hind Paw Edema

The anti-Inflammation activity was determined by the carrageenan-induced Rat hind edema method of Rats (120-140g) used for the experiment. The drugs were prepared as a suspension by triturating with water and 0.5% sodium CMC. The standard group received 40 mg/Kg body weight of indometacin, the test group received 100 mg/Kg body weight of synthesized compounds and the control group received 2% w/v of CMC. The difference between the (zero hours) reading and one of the subsequent readings provides the actual edema volume at that time. The mean paw volume at different times was calculated and compared with the control of percentage inhibition of inflammation after 3 hours .

RESULTS AND DISCUSSION

Chemistry

The synthetic route of the oxazole derivatives is outlined in (scheme. 1). acetophenone was heated with urea in presence of iodine to obtain 4-phenyl)oxazole-2-amine (A). Refluxing of compound (A) with 4-aminobenzaldehyde in ethanol afforded(Z)-N-(4-aminobenzylidine)-4-((E)-penta-2,4-diene-2)oxazole-2-amine (A1) in good yields. Acylation of compound (A) with 4-amino benzoyl chloride in dry pyridine gave N-(4 phenyloxazole-2-yl)- benzamide. (A2). The structure of the synthesized compounds was confirmed by IR and 1H-NMR spectral analysis. 

Anti-Inflammation Activity

The compounds were subjected to anti-inflammation activities by paw edema method using indomethacin drug as standard. All the oxazole derivatives (A, A1, A2) have shown promising anti-inflammation activities, as shown in Table 1.


 

Table 1: Anti-inflammatory activity of thiazole derivatives (A, A1, and A2)

Compound  No.

Mean Paw Edema Volume

0 hour

0.5 hour

1 hour

2 hour

3 hour

% inhibition

after 3rd hour

Control

0.2±0.03

0.44±0.02

0.58±0.02

1.76±0.02

1.82±0.02

----------

Indomethacin

1.22±0.03

1.34±0.02**

1.32±0.02**

1.46±0.02**

1.44±0.02**

45.86

A

0.14±0.04

0.24±0.02*

1.30±0.04**

1.52±0.04**

1.34±0.02**

35.38

A1

1.20±0.05

1.24±0.03*

1.42±0.04**

1.50±0.03**

1.28±0.03**

28.67

A2

1.46±0.02

1.50±0.03*

1.46±0.02**

1.46±0.05**

1.34±0.02**

25.46

*P< 0.05, and **P< 0.01 – significant.

 


 

The differences between ( 0 hours) reading and one of the subsequent readings ( 1, 2, 3, and 4th hour ), respectively, provide the actual edema volume at that time. The mean paw volume at different times was calculated and compared with the control7 Derivatives (A, A1, and A2) showed the percentage inhibition at the 4th   hour (35.38,28.67,), respectively, and the percentage inhibition of Indomethacin drug as ( standard drug) at 4th hour (45.86%). In comparison with Indomethacin as (a standard drug ) to anti-inflammatory activity, compounds A, A1, and A2 have shown significant anti-inflammatory activity. Compounds A1 show excellent anti-inflammatory activity than A and A2 compounds, compared with standard drugs.

CONCLUSION

All the oxazole derivatives have shown promising anti-inflammatory activities. Compounds A1 has shown excellent anti-inflammatory. The results of this study show that the thiazole derivatives (A1 and A2) can be used as an easily accessible source of anti-inflammation in the pharmaceutical industry.

Acknowledgment

The Author is thankful to the Director of the research center at Raffles University for providing their invaluable support and providing all the research facilities. 

Author’s contribution: All authors equally contributed.

Funding source: This research article received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethical approval: Not applicable.

 

Conflicts of interests: There are no conflicts of interests.

REFERENCES

1.    Kakkar S, Narasimhan B. A comprehensive review on biological activities of oxazole derivatives. BMC Chem [Internet]. 2019; 13(3):1–24. Available from: https://doi.org/10.1186/s13065-019-0531-9 

2.    Ahmad H, Ullah S, Rahman F, Saeed A, Pelletier J, Sévigny J, et al. Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors. Eur J Med Chem. 2020; 208. https://doi.org/10.1016/j.ejmech.2020.112759 

3.    Kaur R, Palta K, Kumar M, Bhargava M, Dahiya L. Therapeutic potential of oxazole scaffold: a patent review (2006–2017). Expert Opin Ther Pat [Internet]. 2018; 28(11):783–812. Available from: https://doi.org/10.1080/13543776.2018.1526280 

4.    Zhang HZ, Zhao ZL, Zhou CH. Recent advance in oxazole-based medicinal chemistry. Eur J Med Chem [Internet]. 2018; 144:444–92. Available from: https://doi.org/10.1016/j.ejmech.2017.12.044 

5.    Brunton LLJSLLP. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Vol. 11, JAMA: The Journal of the American Medical Association. 2002. 2052–2052 p. https://doi.org/10.1001/jama.288.16.2052

6.    Ajay Kumar Garg*, Ranjan Kumar Singh , Khushboo Srimali , Saurabh K. Sinha VJ. semicarbazones as anticonvulsant molecules. Adv Pharm J. 2022; 7(1):1–6. 

7.    Shakya AK, Kaur A, Al-Najjar BO, Naik RR. Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as non-steroidal anti-inflammatory agents. Saudi Pharm J [Internet]. 2016; 24(5):616–24. Available from: http://dx.doi.org/10.1016/j.jsps.2015.03.018